Bristol-Myers Squibb to open research site in Cambridge – Plans Kendall Square drug-discovery center
The Boston Globe, Posted: June 25, 2015
By: Robert Weisman and Jack Newsham, Globe Staff and Globe Correspondent
How many big pharma research centers can fit in Cambridge? At least one more.
On Thursday, Bristol-Myers Squibb Co. said it will open a drug-discovery center in Kendall Square in early 2018 with 300 workers to focus on genetic diseases. The 100 Binney St. site will include about 100 researchers from a Waltham lab that is slated to close. The center’s other 200 employees may include many accepting transfers from a Wallingford, Conn., company site also to be shut down as part of a broader Bristol-Myers restructuring.
But the New York-based company, which employs about 450 people at a biologics manufacturing plant in Devens, will probably recruit some new hires from the Boston area, said spokeswoman Sarah Koenig.